HEADER LIGASE 08-MAR-23 8CRJ TITLE CRYSTAL STRUCTURE OF LPLA1 IN COMPLEX WITH LIPOYL-AMP (LISTERIA TITLE 2 MONOCYTOGENES) COMPND MOL_ID: 1; COMPND 2 MOLECULE: LIPOATE--PROTEIN LIGASE; COMPND 3 CHAIN: A; COMPND 4 EC: 6.3.1.20; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: LISTERIA MONOCYTOGENES; SOURCE 3 ORGANISM_TAXID: 1639; SOURCE 4 GENE: AF817_03905, AF817_17765, APD94_04200, APD94_16795, SOURCE 5 D4271_05835, D4271_17085, D4C60_07100, D4C60_17245, D4D89_06525, SOURCE 6 D4D89_17125, D4U23_01750, D4U23_16900, E0I39_06590, E0I39_16500, SOURCE 7 E1V33_06915, E1W43_02450, E1W43_16025, FJU19_06430, FJU19_16220, SOURCE 8 FORC68_0962, G3R95_001339, G3R95_003435, GON91_05790, GT011_03885, SOURCE 9 GT011_16715, GXB45_04655, GXB45_16710, GYP27_11270, GYP27_15895, SOURCE 10 GYU24_04270, GYU24_17075; SOURCE 11 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 12 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS LIPOATE, SALVAGE, ANTI-INFECTIVES, DRUG DEVELOPMENT, LIGASE EXPDTA X-RAY DIFFRACTION AUTHOR J.-N.DIENEMANN,S.-Y.CHEN,M.HITZENBERGER,M.L.SIEVERT,S.M.HACKER, AUTHOR 2 S.T.PRIGGE,M.ZACHARIAS,M.GROLL,S.A.SIEBER REVDAT 3 20-SEP-23 8CRJ 1 REMARK REVDAT 2 02-AUG-23 8CRJ 1 JRNL REVDAT 1 07-JUN-23 8CRJ 0 JRNL AUTH J.N.DIENEMANN,S.Y.CHEN,M.HITZENBERGER,M.L.SIEVERT, JRNL AUTH 2 S.M.HACKER,S.T.PRIGGE,M.ZACHARIAS,M.GROLL,S.A.SIEBER JRNL TITL A CHEMICAL PROTEOMIC STRATEGY REVEALS INHIBITORS OF LIPOATE JRNL TITL 2 SALVAGE IN BACTERIA AND PARASITES. JRNL REF ANGEW.CHEM.INT.ED.ENGL. V. 62 04533 2023 JRNL REFN ESSN 1521-3773 JRNL PMID 37249408 JRNL DOI 10.1002/ANIE.202304533 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0267 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 3 NUMBER OF REFLECTIONS : 21558 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.175 REMARK 3 R VALUE (WORKING SET) : 0.173 REMARK 3 FREE R VALUE : 0.206 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1135 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.67 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1549 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.85 REMARK 3 BIN R VALUE (WORKING SET) : 0.3400 REMARK 3 BIN FREE R VALUE SET COUNT : 82 REMARK 3 BIN FREE R VALUE : 0.3320 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2710 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 116 REMARK 3 SOLVENT ATOMS : 53 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 74.05 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.79000 REMARK 3 B22 (A**2) : -0.79000 REMARK 3 B33 (A**2) : 1.57000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.201 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.160 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 18.018 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.967 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.958 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2872 ; 0.002 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 2715 ; 0.001 ; 0.016 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3866 ; 1.166 ; 1.643 REMARK 3 BOND ANGLES OTHERS (DEGREES): 6253 ; 1.042 ; 1.589 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 334 ; 6.486 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 157 ;32.226 ;23.567 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 506 ;13.146 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 15 ;14.685 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 359 ; 0.040 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3156 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 645 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 5587 ; 0.529 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A -3 A 331 REMARK 3 RESIDUE RANGE : A 401 A 401 REMARK 3 ORIGIN FOR THE GROUP (A): 21.656 46.147 80.382 REMARK 3 T TENSOR REMARK 3 T11: 0.0534 T22: 0.0825 REMARK 3 T33: 0.0137 T12: 0.0118 REMARK 3 T13: 0.0159 T23: -0.0120 REMARK 3 L TENSOR REMARK 3 L11: 0.2852 L22: 0.3848 REMARK 3 L33: 0.6040 L12: -0.0079 REMARK 3 L13: 0.0258 L23: 0.1985 REMARK 3 S TENSOR REMARK 3 S11: 0.0277 S12: -0.0413 S13: -0.0121 REMARK 3 S21: 0.0548 S22: -0.0104 S23: 0.0086 REMARK 3 S31: 0.0258 S32: -0.0325 S33: -0.0173 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : WITH TLS ADDED REMARK 4 REMARK 4 8CRJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 08-MAR-23. REMARK 100 THE DEPOSITION ID IS D_1292129091. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-AUG-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22722 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 200 DATA REDUNDANCY : 4.500 REMARK 200 R MERGE (I) : 0.05300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.70 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : 4.80 REMARK 200 R MERGE FOR SHELL (I) : 0.69100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 8CRI REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 73.30 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.61 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M MES, 1.0 M LICL, 20% PEG 6000, REMARK 280 PH 6.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 112.57000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 39.65500 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 39.65500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 56.28500 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 39.65500 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 39.65500 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 168.85500 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 39.65500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 39.65500 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 56.28500 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 39.65500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 39.65500 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 168.85500 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 112.57000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 97 -16.19 91.48 REMARK 500 ASN A 123 56.79 -148.77 REMARK 500 ASP A 153 53.11 -157.24 REMARK 500 ASP A 168 -175.96 178.52 REMARK 500 ARG A 235 -66.24 -136.51 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 8CRI RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF LPLA1 IN COMPLEX WITH LIPOIC ACID (LISTERIA REMARK 900 MONOCYTOGENES) DBREF1 8CRJ A 1 331 UNP A0A1D2IX29_LISMN DBREF2 8CRJ A A0A1D2IX29 1 331 SEQADV 8CRJ GLY A -3 UNP A0A1D2IX2 EXPRESSION TAG SEQADV 8CRJ SER A -2 UNP A0A1D2IX2 EXPRESSION TAG SEQADV 8CRJ HIS A -1 UNP A0A1D2IX2 EXPRESSION TAG SEQADV 8CRJ MET A 0 UNP A0A1D2IX2 EXPRESSION TAG SEQRES 1 A 335 GLY SER HIS MET MET TYR PHE ILE ASP ASN ASN ASN GLU SEQRES 2 A 335 LYS ASP PRO ARG ILE ASN LEU ALA VAL GLU GLU PHE ILE SEQRES 3 A 335 LEU THR GLU LEU ASN LEU ASP GLU PRO VAL LEU LEU PHE SEQRES 4 A 335 TYR ILE ASN LYS PRO SER ILE ILE ILE GLY ARG ASN GLN SEQRES 5 A 335 ASN THR VAL GLU GLU ILE ASP THR GLU TYR VAL GLU LYS SEQRES 6 A 335 ASN ASP VAL ILE VAL VAL ARG ARG LEU SER GLY GLY GLY SEQRES 7 A 335 ALA VAL TYR HIS ASP GLU GLY ASN LEU ASN PHE SER PHE SEQRES 8 A 335 ILE THR GLU ASP ASP GLY GLU SER PHE HIS ASN PHE ALA SEQRES 9 A 335 LYS PHE THR GLN PRO ILE VAL GLU ALA LEU LYS ARG LEU SEQRES 10 A 335 GLY VAL ASN ALA GLU LEU LYS GLY ARG ASN ASP LEU LEU SEQRES 11 A 335 ILE ASP GLY PHE LYS VAL SER GLY ASN ALA GLN PHE ALA SEQRES 12 A 335 THR LYS GLY LYS MET PHE SER HIS GLY THR LEU MET TYR SEQRES 13 A 335 ASP LEU ASN LEU ASP ASN VAL ALA ALA SER LEU LYS PRO SEQRES 14 A 335 ARG LYS ASP LYS ILE GLU SER LYS GLY ILE LYS SER VAL SEQRES 15 A 335 ARG SER ARG VAL ALA ASN ILE SER ASP PHE MET ASP GLN SEQRES 16 A 335 GLU MET THR THR GLU GLU PHE ARG ASP LEU LEU LEU LEU SEQRES 17 A 335 TYR ILE PHE GLY VAL GLU LYS VAL GLU ASP VAL LYS GLU SEQRES 18 A 335 TYR LYS LEU THR ALA ALA ASP TRP GLU LYS ILE HIS GLU SEQRES 19 A 335 ILE SER ALA LYS ARG TYR GLY ASN TRP ASP TRP ASN TYR SEQRES 20 A 335 GLY LYS SER PRO LYS PHE ASP LEU THR ARG THR LYS ARG SEQRES 21 A 335 PHE PRO VAL GLY ALA VAL ASP VAL ARG LEU ASN VAL GLN SEQRES 22 A 335 LYS GLY VAL ILE THR ASP ILE LYS ILE PHE GLY ASP PHE SEQRES 23 A 335 PHE GLY VAL LYS ASN VAL ALA ASP ILE GLU GLU LYS LEU SEQRES 24 A 335 VAL ASN THR THR TYR LYS ARG GLU VAL LEU ALA GLU ALA SEQRES 25 A 335 LEU VAL ASP ILE ASP VAL LYS GLU TYR PHE GLY ASN ILE SEQRES 26 A 335 THR LYS ASP GLU PHE LEU ASP LEU LEU TYR HET LAQ A 401 34 HET MG A 402 1 HET SO4 A 403 5 HET SO4 A 404 5 HET SO4 A 405 5 HET SO4 A 406 5 HET SO4 A 407 5 HET SO4 A 408 5 HET SO4 A 409 5 HET SO4 A 410 5 HET SO4 A 411 5 HET EDO A 412 4 HET EDO A 413 4 HET EDO A 414 4 HET GOL A 415 6 HET GOL A 416 6 HET GOL A 417 6 HET GOL A 418 6 HETNAM LAQ 5'-O-[(R)-({5-[(3R)-1,2-DITHIOLAN-3-YL]PENTANOYL}OXY) HETNAM 2 LAQ (HYDROXY)PHOSPHORYL]ADENOSINE HETNAM MG MAGNESIUM ION HETNAM SO4 SULFATE ION HETNAM EDO 1,2-ETHANEDIOL HETNAM GOL GLYCEROL HETSYN LAQ LIPOYL-AMP HETSYN EDO ETHYLENE GLYCOL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 LAQ C18 H26 N5 O8 P S2 FORMUL 3 MG MG 2+ FORMUL 4 SO4 9(O4 S 2-) FORMUL 13 EDO 3(C2 H6 O2) FORMUL 16 GOL 4(C3 H8 O3) FORMUL 20 HOH *53(H2 O) HELIX 1 AA1 ASP A 11 GLU A 25 1 15 HELIX 2 AA2 ASN A 49 GLU A 53 5 5 HELIX 3 AA3 ASP A 55 ASP A 63 1 9 HELIX 4 AA4 PHE A 99 ARG A 112 1 14 HELIX 5 AA5 ASN A 155 LEU A 163 1 9 HELIX 6 AA6 ASN A 184 MET A 189 5 6 HELIX 7 AA7 THR A 194 PHE A 207 1 14 HELIX 8 AA8 LYS A 211 VAL A 215 5 5 HELIX 9 AA9 THR A 221 ARG A 235 1 15 HELIX 10 AB1 ASN A 238 TYR A 243 1 6 HELIX 11 AB2 VAL A 288 VAL A 296 1 9 HELIX 12 AB3 LYS A 301 LEU A 309 1 9 HELIX 13 AB4 VAL A 314 GLY A 319 1 6 HELIX 14 AB5 THR A 322 TYR A 331 1 10 SHEET 1 AA1 7 TYR A 2 ILE A 4 0 SHEET 2 AA1 7 VAL A 32 ILE A 37 1 O LEU A 33 N TYR A 2 SHEET 3 AA1 7 ASN A 82 GLU A 90 -1 O SER A 86 N LEU A 34 SHEET 4 AA1 7 LYS A 143 MET A 151 -1 O LEU A 150 N LEU A 83 SHEET 5 AA1 7 PHE A 130 THR A 140 -1 N VAL A 132 O MET A 151 SHEET 6 AA1 7 ASP A 124 ILE A 127 -1 N ILE A 127 O PHE A 130 SHEET 7 AA1 7 GLU A 118 LYS A 120 -1 N LYS A 120 O ASP A 124 SHEET 1 AA2 3 ILE A 65 ARG A 68 0 SHEET 2 AA2 3 SER A 41 ILE A 44 1 N ILE A 44 O VAL A 67 SHEET 3 AA2 3 VAL A 76 HIS A 78 -1 O HIS A 78 N SER A 41 SHEET 1 AA3 4 LYS A 169 SER A 172 0 SHEET 2 AA3 4 PHE A 249 PHE A 257 -1 O THR A 252 N LYS A 169 SHEET 3 AA3 4 GLY A 260 GLN A 269 -1 O VAL A 264 N ARG A 253 SHEET 4 AA3 4 VAL A 272 GLY A 280 -1 O LYS A 277 N ARG A 265 CRYST1 79.310 79.310 225.140 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012609 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012609 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004442 0.00000